EU Health Product Manufacturers Call for Guidance on Flexibility of Claims Wording

09 Feb 2012 --- Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

Feb 9 2012 --- Guidance on the acceptability of flexible wordings when communicating article 13.1 health claims to consumers will be valuable for both enforcement bodies and companies, the European Federation of Associations of Health Product Manufacturers (EHPM) has said.

Welcoming the European Commission’s decision to allow the food sector some flexibility when making claims, EHPM said that because of concerns that the average consumer will not understand some of the scientific terminology, claims should be accompanied by further explanatory details.

“We have concerns whether the average consumer will understand scientific terminology such as ‘Homocystein metabolism’, ‘normal neurotransmission’, ‘cell division and differentiation’ and ‘sulphur amino acid metabolism’,” said EHPM Chairman Peter van Doorn. “Consumers may not interpret correctly many of the wordings listed in the annex of the draft Regulation establishing a list of permitted health claims. Therefore, it is essential that wordings can be adapted to consumer language.”

The European trade association highlighted the dual and equal requirement in the Regulation for claims to be “based on generally accepted scientific evidence” and “well understood by the average consumer”.

EHPM said that based on these requirements companies should be permitted to mention some of the specific functions and definitions cited in the European Food Safety Authority’s (EFSA) opinions, stating that this would provide consumers with valuable advice.
 
“We believe that such clarifications would greatly assist consumer understanding,” said van Doorn. “For example, a message such as ‘Pantothenic acid contributes to normal mental performance’, which relates to EFSA’s definition of mental performance as standing for those aspects of brain and nerve functions which determine aspects like concentration, learning, memory and reasoning. We hope that the European Commission and Member States take into consideration this approach with regard to flexibility.”

Related Articles

Nutrition & Health News

Food for the heart (Part 1): Opportunities, challenges and delivery forms

16 Oct 2017 --- Heart health is literally a matter of life and death – according to the US Centers for Disease Control and Prevention (CDC), about 610,000 people die of heart disease in the US every year. This means that it accounts for 1 in every 4 deaths. Indeed, heart disease is the leading cause of death for both men and women, so potential nutritional solutions are at the forefront of companies’ thinking.

Business News

Neptune chief eyes strong potential for new cannabis business as executive appointments installed

05 Oct 2017 --- Wellness products company Neptune Wellness Solutions has appointed Michel Timperio as President of its new Cannabis Business and Melody Harwood as Head of Scientific and Regulatory Affairs. Timperio will report to Jim Hamilton, President and CEO of Neptune. 

Nutrition & Health News

Beauty from within presents attractive options despite regional challenges

29 Sep 2017 --- The beauty-from-within space has been gaining traction over recent years, with a number of key ingredients piquing the interest of consumers and suppliers alike. Today, NutritionInsight looks at some of the regional differences, challenges and opportunities this space offers.

Nutrition & Health News

NP Nutra introduces Triple-T Verification Program

26 Sep 2017 --- Nature’s Power Nutraceuticals Corp (NP Nutra), a wholesale supplier of premium nutraceutical ingredients is to launch its Triple-T Verification Program at Supply Side West, which aims to guarantee the quality and traceability of its supply chain.

Food Ingredients News

Organic AstaPure astaxanthin verified by Non-GMO Project

19 Sep 2017 --- Algatechnologies’ organic Haematococcus pluvialis microalgae powder and astaxanthin oleoresin have been granted non-GMO verification by the Non-GMO Project. Algatech is the first astaxanthin manufacturer to attain this verification.

More Articles
URL : http://www.nutritioninsight.com:80/news/EU-Health-Product-Manufacturers-Call-for-Guidance-on-Flexibility-of-Claims-Wording.html